Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3...

Investigational New Drugs 2011 / 02 Vol. 29; Iss. 1

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors

Neeltje Steeghs, Hans Gelderblom, Judith Wessels, Ferry A. L. M. Eskens, Natasja de Bont, Johan W. R. Nortier, Henk-Jan Guchelaar
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Pages:
7
DOI:
10.1007/s10637-009-9347-0
Date:
February, 2011
File:
PDF, 130 KB
english, 2011
Conversion to is in progress
Conversion to is failed